In addition, propofol is more effective in inducing apoptosis and inhibiting colony formation in CML CD34 progenitor cells than normal bone marrow (NBM) counterparts. The gene discussed is CD34; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.